glp-1 and dementia Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline in Diabetes Mellitus Glucose-lowering therapies may reduce risk

doi: 10.1186/s13023-021-01685-9 113 FilippiLGozziniECavicchiCMorroneAFioriniPDonzelliGet al

With the high prevalence of ASD, treatments that successfully treat even only a fraction of children affected with ASD would translate into substantial benefits for millions of individuals with ASD and their families

Dual GLP-1/GIP receptor agonists represent a newer therapeutic class

Some find it helps manage stress, which might lower migraine frequency

Experience the synergistic power of glycine, cysteine, and glutamic acid in our Glutathione chews formulated for convenient daily support of antioxidant activity and liver wellness

For example, if MTHFR is down regulated, we can make up for the lack of methylfolate by supplementing with activated folate at doses that are right for you